Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
Kasper Sommerlund MoestrupJoanne ReekieAdrian G ZuccoTomas Ø JensenJens Ulrik S JensenLothar WieseSisse R OstrowskiCarsten U NiemannCameron MacPhersonJens LundgrenMarie HellebergPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Post-discharge readmission and mortality rates were substantial. Therefore, sustained recovery should be favored to recovery outcomes in clinical COVID-19 trials. A 28-day follow-up period may be too short the critically ill.